Advanced Prostate Cancer

Also known as: Prostatic neoplasms malignant / Ca prostate / Malignant tumor of prostate (disorder) / Prostatic cancer / Prostate cancer NOS / Cancer of prostate / Prostate cancer / Malignant neoplasm of prostate / Primary malignant neoplasm of prostate (disorder)

DrugDrug NameDrug Description
DB06699DegarelixA GnRH receptor antagonist used in the management of advanced prostate cancer.
DB06788HistrelinA GnRH agonist found in subcutaneous implants used for the treatment of pediatric patients with central precocious puberty and the palliative treatment of advanced prostate cancer.
DB00007LeuprolideA peptide-based GnRH receptor superagonist used for the palliative treatment of prostate cancer, uterine leiomyomata, endometriosis, and central precocious puberty.
DB11853RelugolixAn oral GnRH receptor antagonist for androgen deprivation therapy in the treatment of advanced prostate cancer.
DB06825TriptorelinA GnRH agonist indicated for the palliative treatment of advanced prostate cancer.
DrugDrug NamePhaseStatusCount
DB05812Abiraterone0Active Not Recruiting1
DB00644Gonadorelin0Active Not Recruiting1
DB00635Prednisone0Active Not Recruiting1
DB13146Fluciclovine (18F)1Not Yet Recruiting1
DB01248Docetaxel3Unknown Status1
DB06699DegarelixNot AvailableCompleted1
DB00644GonadorelinNot AvailableCompleted1
DB00007LeuprolideNot AvailableCompleted1
DB08913Radium Ra 223 dichlorideNot AvailableUnknown Status1
DB12813Radium Ra-223Not AvailableUnknown Status1
DB06688Sipuleucel-TNot AvailableCompleted1